Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea

Study Identifier
199201-001
CT.gov Identifier
NCT01579084
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dermatology - Other
    • Study Drug
  • AGN-199201 Formulation A
  • AGN-199201 Formulation B
  • AGN-199201 Formulation C
  • AGN-199201 Vehicle
    • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * facial erythema associated with rosacea on both sides of the face
    Exclusion Criteria:
    * Laser light-source or other energy based therapy in the last 6 months * Excessive hair around the treatment area

    Protocol Summary

    This study will evaluate the safety and tolerability of AGN-199201 for the treatment of erythema associated with rosacea.

    Study Locations

    Location
    Status
    Location
    Austin, Texas, United States
    Status
    Not applicable